{"id":"https://openalex.org/W7117308844","doi":"https://doi.org/10.1002/alz70859_103679","title":"Targeting SEMA4D/PLXN signaling through reactive glia as a common pathology for the treatment of neurodegenerative disorders","display_name":"Targeting SEMA4D/PLXN signaling through reactive glia as a common pathology for the treatment of neurodegenerative disorders","publication_year":2025,"publication_date":"2025-12-01","ids":{"openalex":"https://openalex.org/W7117308844","doi":"https://doi.org/10.1002/alz70859_103679","pmid":"https://pubmed.ncbi.nlm.nih.gov/41450039"},"language":"en","primary_location":{"id":"doi:10.1002/alz70859_103679","doi":"https://doi.org/10.1002/alz70859_103679","is_oa":true,"landing_page_url":"https://doi.org/10.1002/alz70859_103679","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz70859_103679","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz70859_103679","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001292309","display_name":"Elizabeth E. Evans","orcid":"https://orcid.org/0000-0002-9287-9221","observed_orcids":["https://orcid.org/0000-0002-9287-9221"]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Elizabeth E Evans","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022624265","display_name":"Terrence Lee Fisher","orcid":"https://orcid.org/0000-0001-9326-6606","observed_orcids":["https://orcid.org/0000-0001-9326-6606"]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terrence L Fisher","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088601928","display_name":"Vikas A. Mishra","orcid":"https://orcid.org/0000-0002-4555-0132","observed_orcids":["https://orcid.org/0000-0002-4555-0132"]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vikas Mishra","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009743534","display_name":"Leslie Balch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Balch","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076172830","display_name":"Elaine M. Gersz","orcid":"https://orcid.org/0009-0008-5384-7084","observed_orcids":["https://orcid.org/0009-0008-5384-7084"]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elaine E Gersz","raw_affiliation_strings":["Vaccinex, Inc, Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc, Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108739609","display_name":"Alan P. Howell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Howell","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111030711","display_name":"Renee Kirk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renee Kirk","raw_affiliation_strings":["Vaccinex, Inc, Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc, Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092705018","display_name":"Malgorzata Gil-Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malgorzata Gil\u2010Moore","raw_affiliation_strings":["Vaccinex, Inc, Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc, Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114035061","display_name":"Crystal L. Mallow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Crystal L Mallow","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023884039","display_name":"Amber Foster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amber Foster","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033585095","display_name":"Anton P. Porsteinsson","orcid":"https://orcid.org/0000-0002-0166-1738","observed_orcids":["https://orcid.org/0000-0002-0166-1738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anton P Porsteinsson","raw_affiliation_strings":["Alzheimer\u2019s Disease Care, Research and Education Program (AD\u2010CARE), Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer\u2019s Disease Care, Research and Education Program (AD\u2010CARE), Rochester, NY USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091782250","display_name":"Andrew Feigin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Feigin","raw_affiliation_strings":["NYU Langone Health, New York, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Health, New York, NY USA","institution_ids":["https://openalex.org/I4210086933"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089699061","display_name":"Maurice Zauderer","orcid":"https://orcid.org/0000-0002-4253-9165","observed_orcids":["https://orcid.org/0000-0002-4253-9165"]},"institutions":[{"id":"https://openalex.org/I4210141595","display_name":"Vaccinex (United States)","ror":"https://ror.org/047jxj944","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maurice Zauderer","raw_affiliation_strings":["Vaccinex, Inc., Rochester, NY USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccinex, Inc., Rochester, NY USA","institution_ids":["https://openalex.org/I4210141595"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001292309"],"corresponding_institution_ids":["https://openalex.org/I4210141595"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":{"value":4200,"currency":"USD","value_usd":4200},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42813799,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"S5","first_page":"e103679","last_page":"e103679"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.03009999915957451,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sema4d","display_name":"Sema4D","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cd100","display_name":"CD100","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.7254999876022339},{"id":"https://openalex.org/C2777542381","wikidata":"https://www.wikidata.org/wiki/Q502961","display_name":"Astrocyte","level":3,"score":0.6891999840736389},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6187000274658203},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6176000237464905},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.5277000069618225},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.49300000071525574},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.45350000262260437},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.427700012922287},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41929998993873596},{"id":"https://openalex.org/C2777682930","wikidata":"https://www.wikidata.org/wiki/Q1531490","display_name":"Gliosis","level":2,"score":0.4154999852180481},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.39969998598098755},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.391400009393692},{"id":"https://openalex.org/C112313634","wikidata":"https://www.wikidata.org/wiki/Q7886648","display_name":"Complement (music)","level":5,"score":0.38350000977516174},{"id":"https://openalex.org/C2992208609","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neuronal degeneration","level":3,"score":0.3790000081062317},{"id":"https://openalex.org/C2780884517","wikidata":"https://www.wikidata.org/wiki/Q177105","display_name":"Neuroglia","level":3,"score":0.33469998836517334},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3292999863624573},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3237000107765198},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.31850001215934753},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.30300000309944153},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.28209999203681946},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C189446657","wikidata":"https://www.wikidata.org/wiki/Q4736500","display_name":"Alternative complement pathway","level":4,"score":0.2653000056743622},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C2777427615","wikidata":"https://www.wikidata.org/wiki/Q954257","display_name":"Degenerative disease","level":3,"score":0.2574999928474426},{"id":"https://openalex.org/C2909079248","wikidata":"https://www.wikidata.org/wiki/Q954257","display_name":"Degenerative Disorder","level":3,"score":0.2572999894618988},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2565999925136566},{"id":"https://openalex.org/C172268261","wikidata":"https://www.wikidata.org/wiki/Q4764988","display_name":"Animal studies","level":2,"score":0.25589999556541443},{"id":"https://openalex.org/C2779354088","wikidata":"https://www.wikidata.org/wiki/Q15467261","display_name":"Degeneration (medical)","level":2,"score":0.25450000166893005},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2540000081062317}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039961","descriptor_name":"Semaphorins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D039961","descriptor_name":"Semaphorins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/alz70859_103679","doi":"https://doi.org/10.1002/alz70859_103679","is_oa":true,"landing_page_url":"https://doi.org/10.1002/alz70859_103679","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz70859_103679","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},{"id":"pmid:41450039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41450039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & dementia : the journal of the Alzheimer's Association","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12741495","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12741495/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alzheimers Dement","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/alz70859_103679","doi":"https://doi.org/10.1002/alz70859_103679","is_oa":true,"landing_page_url":"https://doi.org/10.1002/alz70859_103679","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz70859_103679","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6325517296791077,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7117308844.pdf","grobid_xml":"https://content.openalex.org/works/W7117308844.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"Semaphorin":[1],"4D":[2],"(SEMA4D,":[3],"CD100)":[4],"and":[5,27,39,54,66,98,107,120,131,143,184,197,204,210,241,262,283,287,298,303,314,318,335,347],"its":[6],"receptors":[7],"Plexin":[8],"B1,":[9],"B2":[10],"have":[11],"been":[12],"identified":[13],"in":[14,30,51,61,78,88,136,145,207,229,244,249,259,272,301],"multiple":[15,103],"transcriptomic/genomic":[16],"studies":[17,109,308],"as":[18],"a":[19,72,137,213],"key":[20],"signaling":[21],"pathway":[22],"associated":[23,115,274,319],"with":[24,116,159,170,275,322],"reactive":[25,117,276],"gliosis":[26],"disease":[28,190],"risk":[29],"Alzheimer's":[31],"Disease":[32,35],"(AD),":[33],"Huntington's":[34],"(HD),":[36],"Multiple":[37],"Sclerosis,":[38],"vascular":[40,132,223,320],"dementia.":[41],"Our":[42],"lab":[43],"has":[44],"reported":[45],"that":[46,310],"SEMA4D":[47,81,126,192],"protein":[48],"is":[49,234],"upregulated":[50],"diseased":[52],"neurons":[53],"activates":[55],"astrocytes":[56,277],"via":[57],"receptor":[58],"binding,":[59],"resulting":[60],"downregulation":[62],"of":[63,68,96,125,140,222,226,256,267,340],"metabolic":[64,86],"transporters":[65],"release":[67],"inflammatory":[69,299],"cytokines.":[70],"In":[71,150,188,212,236],"completed":[73],"randomized":[74],"Phase":[75],"2":[76],"study":[77],"HD":[79,141,302],"(NCT02481674),":[80],"blocking":[82,193],"antibody":[83,194],"pepinemab":[84,111,171,218,238,323],"prevented":[85],"decline":[87,101,258],"glucose":[89],"uptake":[90],"(FDG-PET)":[91],"reduced":[92,195],"plasma":[93],"GFAP,":[94],"biomarkers":[95,273],"astrogliosis,":[97],"slowed":[99],"cognitive":[100,104,121,245,257,345],"employing":[102],"scales.":[105],"Mechanistic":[106],"clinical":[108],"investigate":[110],"effects":[112],"on":[113,128],"changes":[114],"gliosis,":[118],"neuroinflammation,":[119],"decline.":[122],"METHOD:":[123],"Effects":[124],"blockade":[127],"neuropathology,":[129],"behavior,":[130],"integrity":[133],"were":[134,165,247],"evaluated":[135],"mouse":[138],"model":[139,233],"(Hu97/18)":[142],"an":[144,327],"vitro":[146],"brain":[147,215,231,316],"chip":[148,216,232],"model.":[149],"the":[151,230,250,291,337],"phase":[152],"1b/2":[153],"SIGNAL-AD":[154],"trial":[155],"(NCT04381468),":[156],"50":[157],"individuals":[158],"mild":[160],"AD":[161,252],"dementia":[162],"(MMSE":[163],"17-26)":[164],"treated":[166],"for":[167],"12":[168],"months":[169],"(40":[172],"mg/kg)":[173],"or":[174,330],"placebo,":[175],"Q4W,":[176],"IV":[177],"infusion.":[178],"Key":[179],"objectives":[180],"included":[181],"safety,":[182],"cognition,":[183],"biomarker":[185],"assessments.":[186],"RESULT:":[187],"preclinical":[189],"models,":[191],"astrocyte":[196,312],"microglial":[198],"activation":[199,297,313],"markers,":[200,203],"increased":[201],"synaptic":[202],"improved":[205],"deficits":[206],"spatial":[208],"learning":[209],"memory.":[211],"human":[214],"model,":[217],"restored":[219],"\u03b1-synuclein-induced":[220],"disruption":[221,321],"integrity.":[224],"Evaluation":[225],"amyloid-induced":[227],"damage":[228],"ongoing.":[235],"SIGNAL-AD,":[237],"was":[239],"well-tolerated":[240],"meaningful":[242],"improvements":[243],"assessments":[246],"observed":[248],"MCI-early":[251],"subgroup":[253],"(>70%":[254],"slowing":[255],"CDR-SB,":[260],"iADRS,":[261],"ADAS-Cog13).":[263],"O-link":[264],"proteomic":[265],"analysis":[266],"CSF":[268],"revealed":[269],"treatment-related":[270],"reductions":[271],"(GFAP),":[278],"microglia":[279],"clearance":[280],"(LILRB4,":[281],"MARCO),":[282],"tau":[284],"pathology":[285],"(GAP-43":[286],"SNAP25).":[288],"CONCLUSION:":[289],"Given":[290],"many":[292],"physiological":[293],"parallels":[294],"between":[295],"glial":[296,341],"processes":[300],"AD,":[304],"results":[305],"from":[306],"these":[307],"suggest":[309],"preventing":[311],"reducing":[315],"inflammation":[317],"treatment":[324],"could":[325],"be":[326],"attractive":[328],"alternative":[329],"complement":[331],"to":[332,343],"anti-A\u03b2":[333],"antibodies":[334],"support":[336],"broad":[338],"application":[339],"regulators":[342],"treat":[344],"dysfunction":[346],"neurodegenerative":[348],"disease.":[349]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-12-26T00:00:00"}